228 related articles for article (PubMed ID: 29676157)
1. A High-Throughput Assay for Collagen Secretion Suggests an Unanticipated Role for Hsp90 in Collagen Production.
Wong MY; Doan ND; DiChiara AS; Papa LJ; Cheah JH; Soule CK; Watson N; Hulleman JD; Shoulders MD
Biochemistry; 2018 May; 57(19):2814-2827. PubMed ID: 29676157
[TBL] [Abstract][Full Text] [Related]
2. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.
Mishra SJ; Ghosh S; Stothert AR; Dickey CA; Blagg BS
ACS Chem Biol; 2017 Jan; 12(1):244-253. PubMed ID: 27959508
[TBL] [Abstract][Full Text] [Related]
3. Heat Shock Protein 90 Inhibitor Decreases Collagen Synthesis of Keloid Fibroblasts and Attenuates the Extracellular Matrix on the Keloid Spheroid Model.
Lee WJ; Lee JH; Ahn HM; Song SY; Kim YO; Lew DH; Yun CO
Plast Reconstr Surg; 2015 Sep; 136(3):328e-337e. PubMed ID: 26313837
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.
Weber H; Valbuena JR; Barbhuiya MA; Stein S; Kunkel H; García P; Bizama C; Riquelme I; Espinoza JA; Kurtz SE; Tyner JW; Calderon JF; Corvalán AH; Grez M; Pandey A; Leal-Rojas P; Roa JC
Oncotarget; 2017 Apr; 8(16):26169-26184. PubMed ID: 28412732
[TBL] [Abstract][Full Text] [Related]
5. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.
Stravopodis DJ; Margaritis LH; Voutsinas GE
Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746
[TBL] [Abstract][Full Text] [Related]
6. Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects.
Chan CT; Reeves RE; Geller R; Yaghoubi SS; Hoehne A; Solow-Cordero DE; Chiosis G; Massoud TF; Paulmurugan R; Gambhir SS
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2476-85. PubMed ID: 22895790
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
8. Heat Shock Protein 90 Inhibitor Decreases Collagen Synthesis of Keloid Fibroblasts and Attenuates the Extracellular Matrix on the Keloid Spheroid Model.
Liu Q; Wang X; Jia Y
Plast Reconstr Surg; 2016 Apr; 137(4):759e-760e. PubMed ID: 26752358
[No Abstract] [Full Text] [Related]
9. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
[TBL] [Abstract][Full Text] [Related]
10. High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888.
Lyman SK; Crawley SC; Gong R; Adamkewicz JI; McGrath G; Chew JY; Choi J; Holst CR; Goon LH; Detmer SA; Vaclavikova J; Gerritsen ME; Blake RA
PLoS One; 2011 Mar; 6(3):e17692. PubMed ID: 21408192
[TBL] [Abstract][Full Text] [Related]
11. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.
Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Younes A
Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164
[TBL] [Abstract][Full Text] [Related]
12. The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice.
Abu-Elsaad NM; Serrya MS; El-Karef AM; Ibrahim TM
Pharmacol Rep; 2016 Apr; 68(2):275-82. PubMed ID: 26922527
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.
Krishnamoorthy GP; Guida T; Alfano L; Avilla E; Santoro M; Carlomagno F; Melillo RM
J Biol Chem; 2013 Jun; 288(24):17481-94. PubMed ID: 23629654
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of the HSP90 molecular chaperone: current status.
Sharp S; Workman P
Adv Cancer Res; 2006; 95():323-48. PubMed ID: 16860662
[TBL] [Abstract][Full Text] [Related]
15. Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
Chai RC; Kouspou MM; Lang BJ; Nguyen CH; van der Kraan AG; Vieusseux JL; Lim RC; Gillespie MT; Benjamin IJ; Quinn JM; Price JT
J Biol Chem; 2014 May; 289(19):13602-14. PubMed ID: 24692538
[TBL] [Abstract][Full Text] [Related]
16. Assay strategies for the discovery and validation of therapeutics targeting Brugia pahangi Hsp90.
Taldone T; Gillan V; Sun W; Rodina A; Patel P; Maitland K; O'Neill K; Chiosis G; Devaney E
PLoS Negl Trop Dis; 2010 Jun; 4(6):e714. PubMed ID: 20559560
[TBL] [Abstract][Full Text] [Related]
17. Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets.
Kasperkiewicz M; Müller R; Manz R; Magens M; Hammers CM; Somlai C; Westermann J; Schmidt E; Zillikens D; Ludwig RJ; Orosz A
Blood; 2011 Jun; 117(23):6135-42. PubMed ID: 21490339
[TBL] [Abstract][Full Text] [Related]
18. A novel class of small molecule inhibitors of Hsp90.
Yi F; Regan L
ACS Chem Biol; 2008 Oct; 3(10):645-54. PubMed ID: 18785742
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Targeting of the ER-Resident Chaperones GRP94 or Cyclophilin B Induces Secretion of IL-22 Binding Protein Isoform-1 (IL-22BPi1).
Gómez-Fernández P; Urtasun A; Astobiza I; Mena J; Alloza I; Vandenbroeck K
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108847
[TBL] [Abstract][Full Text] [Related]
20. Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells.
Cheung CH; Chen HH; Cheng LT; Lyu KW; Kanwar JR; Chang JY
Mol Cancer; 2010 Apr; 9():77. PubMed ID: 20398291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
